Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
TBE Meningococcal Disease Influenza Smallpox
 


 
Login to Healthcare Professionals

If you are not registered yet, » register here.

E-Mail:  
Password:  
» login


Product Information

Tick-borne encephalitis virus (TBEV) is one of the major human pathogenic flaviviruses. It may cause serious diseases in humans where it may affect the central nervous system with clinical features such as meningitis and encephalitis of different severity.

No causal treatment against TBE is possible, but a very efficient, safe and well-tolerated TBE vaccine is available to ensure the necessary protection.

In more than 25 years of experience with the TBE vaccine by Baxter Vaccine AG, this vaccine has been shown to be safe and highly immunogenic in the prevention of this life-threatening disease.

For any further information about Baxter's TBE vaccine, please contact your physician.

 » Printversion

 
 
  » find


 

Baxter Receives EMEA Positive Opinion for CELVAPAN, the First Cell Culture-based Pandemic Flu Vaccine
» read more

The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
» read more

U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCīs DVC and Baxter
» read more

 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,